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Objectives: Melioidosis is a potentially fatal infectious disease caused by the
environmental anaerobic Gram-negative bacillus Burkholderia pseudomallei.
Melioidosis is endemic to areas of northern Australia and Southeast Asia. With
increasing international travel and migration, imported cases of melioidosis are
being reported regularly. Here, we summarize the 11 cases of melioidosis re-
ported in South Korea from 2003 to 2014.
Methods: Tracing epidemiological investigations were performed on every pa-
tient reported to the National Surveillance System since 2011. A systematic
literature search was performed to identify melioidosis cases that occurred prior
to 2011.
Results: The overall fatality rate was 36.4%. All the patients had visited South-
east Asia where melioidosis is endemic. The stay in the endemic region ranged
from 4 days to 20 years. Of the seven patients who developed initial symptoms
after returning to South Korea, the time interval between returning to South
Korea and symptom onset ranged from 1 day to 3 years. The remaining four
patients developed symptoms during their stay in the endemic region and were
diagnosed with melioidosis in South Korea. Seven (63.6%) patients possessed at
least one risk factor, all of whom were diabetic. Pneumonia was the most
frequent clinical manifestation, but the patients showed a wide spectrum of
clinical features, including internal organ abscesses, a mycotic aneurysm of the
aorta, and coinfection with tuberculosis.
Conclusion: An early diagnosis and initiation of the appropriate antibiotics can
reduce the mortality of melioidosis. Consequently, increased awareness of the
risk factors and clinical features of melioidosis is required.uted under the terms of the Creative Commons Attribution-NonCommercial-No Derivative
.org/licenses/by-nc-nd/4.0) which permits non-commercial use, distribution, and repro-
ginal author and source are credited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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Melioidosis is a potentially fatal infectious disease
caused by the environmental anaerobic Gram-negative
bacillus Burkholderia pseudomallei. Melioidosis is
endemic to areas of northern Australia and Southeast
Asia, including Thailand, Malaysia, Cambodia, Laos,
and Vietnam [1]. B. pseudomallei dwells in soil and
water, and is transmitted via percutaneous inoculation,
inhalation, or the ingestion of infected food or water.
Consequently, individuals in regular contact with soil
and water are frequently affected [2]. Melioidosis shows
a wide range of clinical manifestations with varying
severity. Pneumonia is the most frequent presenting
feature, followed by genitourinary infection, skin
infection, septic arthritis, and osteomyelitis [3].
Disseminated abscess formation in the internal organs is
the hallmark of melioidosis. With increasing interna-
tional travel and migration, cases of melioidosis im-
ported from endemic regions are being reported
regularly, and it is important that physicians should be
more aware of melioidosis. In South Korea, there were
11 known cases of melioidosis from 2003 to 2014, and
the first six of these cases had been reported previously
[4e9]. Here, we summarize the epidemiological and
clinical manifestations of the imported melioidosis in
South Korea.2. Materials and methods
2.1. Case series
Melioidosis was designated as a national notifiable
infectious disease on December 30, 2010. Since then, a
national melioidosis surveillance system has been
established, and medical institutions are responsible for
reporting all melioidosis cases to that system. Five cases
of melioidosis have been reported to the system since
2011. However, little was known about melioidosis
prior to establishment of the National Surveillance
System. Thus, a systematic literature search was per-
formed using PubMed and the Korean Medical Data-
base, with the following keywords “melioidosis” and
“Burkholderia pseudomallei” to identify melioidosis
cases that occurred before 2011. As a result, six cases
were found.
2.2. Epidemiological and clinical data
Tracing epidemiological investigations were per-
formed on every patient reported to the National Sur-
veillance System since 2011. The epidemiological
investigations were performed by Epidemic Intelligence
Service officers via patient interviews and retrospective
review of medical records. The standard questionnaire
included the following variables: basic demographic
characteristics (age, sex, address, and occupation),
clinical features (presenting symptoms, date of onset,mortality, and laboratory and imaging results), melioi-
dosis risk factors (underlying diseases and alcohol
consumption), history of visiting other countries, and
suspected exposure (presence of skin wounds, a history
of inhaling dust, ingesting infected water, or contact
with a patient with melioidosis). We collected data on
cases that occurred prior to 2011 by reviewing earlier
reports.3. Results
3.1. Demographic features
Since the first report in 2003, 11 cases of imported
melioidosis have been reported in South Korea. The
mean age of the patients was 52.3 years, ranging from
32 years to 66 years. Ten patients (90.9%) were older
than 45 years, and all patients were male. With regard to
their occupations, the patients included businessmen
(36.3%), construction workers (18.2%), welders
(18.2%), engineers (9.1%), drivers (9.1%), and actors
(9.1%). The demographic, epidemiologic, and clinical
features of the patients are summarized in Table 1.
3.2. Epidemiologic features
All the patients had visited Southeast Asia, which is a
traditional endemic region for melioidosis. The coun-
tries from which melioidosis were imported included
Malaysia (27.3%), Thailand (27.3%), Cambodia
(18.2%), Philippines (9.1%), Indonesia (9.1%), and
Vietnam (9.1%). Domestic cases of melioidosis have
never been reported in South Korea, based on previous
epidemiological investigations, and so all cases are
thought to be imported. Nine patients had stayed in the
endemic region for >1 month. However, two patients
developed melioidosis after a few days of travel to the
endemic region. Four patients developed symptoms
during their stay in the endemic region and were diag-
nosed with melioidosis after returning to South Korea.
The remaining seven patients developed initial symp-
toms after returning to South Korea. Of these patients,
the interval between returning to South Korea and
symptom onset ranged from 1 day to 3 years. Seven
patients had at least one risk factor for melioidosis.
Diabetes mellitus was the most frequent risk factor
(63.6%), followed by lung cancer (9.1%) and chronic
kidney disease (9.1%).
3.3. Clinical manifestations
Eight patients had acute infections (symptom duration
of<2months) and three had chronic infection (symptoms
for > 2 months). Of these 11 patients seven (63.6%)
presented with pneumonia, three (27.3%) with genito-
urinary infection, and one (9.1%) with soft tissue infec-
tion. Abscess formation was observed in the prostate in
three patients, and in the spleen and liver in one patient.
Three patients had septic shock on admission with
Table 1. Clinical features and results of evaluations of melioidosis patients in South Korea, 2003 to 2014.
Characteristics
Case
Seok et al [4] Lee et al [5] Lee et al [6] Son et al [7] Park et al [8] Hong et al [9] Case 1 Case 2 Case 3 Case 4 Case 5
Year 2003 2004 2008 2008 2010 2010 2011 2013 2013 2014 2014
Age (y) 47 50 32 47 55 48 60 47 66 61 62
Sex Male Male Male Male Male Male Male Male Male Male Male
Country visited Malaysia Indonesia Thailand Cambodia Malaysia Malaysia Philippines Thailand Cambodia Vietnam Thailand
Occupation Engineer Businessman Driver Welder Construction
worker
Construction
worker
Welder Businessman Actor Businessman Businessman
Length of stay 1 year 20 years 30 years 4 days 2 years 4 months 8 months 7 days 1 months 9 years 1 month
Return to onset 3 years During stay 6 weeks 1 month During stay During stay 9 months 1 day 50 days 2 months During stay
Risk factors Diabetes None Diabetes Diabetes None Diabetes None Diabetes,
CKD
Diabetes Diabetes,
cancer
None
Acute/chronic Acute Chronic Acute Acute Acute Acute Chronic Acute Acute Acute Chronic
Presenting
symptoms
Fever Fever, cough,
myalgia
Dyspnea Dyspnea Facial swelling,
fever
Dysuria, fever Cough Fever Fever,
dysuria
Fever, cough Fever, dysuria
Clinical
manifestation
Pneumonia Pneumonia Pneumonia Pneumonia Soft tissue
infection
GU infection Pneumonia Pneumonia GU
infection
Pneumonia GU infection
Shock on
admission
Absent Absent Present Present Absent Absent Absent Absent Present Absent Absent
CXR/chest CT Multiple
nodules
Multiple
nodules
Multiple
nodules
Ill-defined
opacity
Normal Patchy
opacities
Mass-like
consolidation
GGO GGO Consolidation,
lung cancer
Multiple
nodules
Other findings Spleen/liver
abscess
Head/neck
abscess
Prostate
abscess
Prostate
abscess
Hand swelling Prostate abscess,
aortic aneurysm
Diagnosis Blood
culture
Bronchoscopic
washing culture
Blood
culture
Blood
culture
Blood
& abscess
culture
Blood
& abscess
culture
Tissue (lung)
& sputum
culture
Blood
culture
Blood
culture
Blood culture Tissue (aorta)
& blood
culture
Bacteremia Present Absent Present Present Present Present Absent Present Present Present Present
Outcome Survived Survived Died Died Died Survived Survived Survived Died Survived Survived
CKD Z chronic kidney disease; CT Z computed tomography; CXR Z chest x-ray; GGO Z ground-glass opacity; GU Z genitourinary.
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366 S.W. Kim, et alevidence of organ dysfunction, all of whom underwent
rapid progression of the disease and died. Nine patients
were bacteremic. In the remaining two patients, B.
pseudomallei grew in bronchoscopic washing and surgi-
cal specimen obtained by pulmonary lobectomy. Four
patients died and seven patients survived without relapse.
Of the five patients reported since 2011, two patients
showed unusual clinical manifestation. Case 1 had a
coinfection with pulmonary tuberculosis and melioi-
dosis. The patient initially presented with chronic cough,
and Mycobacterium tuberculosis was cultured in a lung
biopsy. The patient underwent antitubercular therapy.
However, the cough persisted, and the patient underwent
a left upper lobectomy more than a year after returning
from the endemic region. The surgical specimen grew B.
pseudomallei. Case 5 was the first melioidosis patient in
South Korea presented with a mycotic aneurysm of the
aorta. The patient initially developed dysuria and was
diagnosed with a prostate abscess. Although fever sub-
sided after the treatment, fever recurred about 50 days
after its onset. The subsequent diagnostic workup
revealed a mycotic aneurysm of the aorta. The patient
underwent surgical treatment of the aneurysm, and
blood and the surgical specimen grew B. pseudomallei.4. Discussion
Here, we summarized the reported cases of melioi-
dosis in South Korea. A total of 11 cases of melioidosis
were reported during the past 12 years, and the overall
fatality rate was 36.4%. All the patients had visited
Southeast Asia, where melioidosis is endemic. Most of
the cases stayed in the endemic area for months to years,
and developed symptoms before returning to South
Korea or within a few months after the return. However,
some cases stayed in the endemic region for as little as a
few days, and one case developed symptoms 3 years
after returning to South Korea. Pneumonia was the most
frequent clinical manifestation, but the patients showed
a wide spectrum of clinical features, including a mycotic
aneurysm of the aorta and coinfection with tuberculosis.
An early diagnosis and initiation of the appropriate an-
tibiotics can reduce mortality. Consequently, increased
awareness of the risk factors and clinical features of
melioidosis is required.
Most melioidosis cases result from recent exposure, as
the majority of melioidosis cases in the endemic region
occur during the rainy season. The incubation period of
melioidosis ranges from days to months [10]. A previous
study calculated an incubation period of 1e21 days be-
tween the inoculating event and symptom onset [11].
However, B. pseudomallei can reactivate after an initial
asymptomatic infection with extremely prolonged la-
tency. There are reports of melioidosis becoming symp-
tomatic more than 20 years after the suspected exposure
[12,13]. In this report, incubation periods could not bedetermined clearly, as most of the patients failed to recall
the actual event of inhalation or inoculation. Therefore,
the time period between returning to South Korea and the
onset of symptoms was recorded as an indirect measure
of the minimum incubation period. More than half of the
cases developed symptoms during their stay in the
endemic region or within 1 month after returning to South
Korea. However, the initial symptoms developed more
than 1 month after returning to South Korea in five cases,
and the interval between return and symptom manifes-
tation was as long as 3 years in one case [4]. Although
poorly understood, the prolonged latency of B. pseudo-
mallei is thought to be associated with its facultative
anaerobic nature, ability to persist without nutrients, and
ability to endure antibiotic pressure by assuming fila-
mentous forms [14]. It is important that physicians should
not rule out melioidosis simply because the duration from
the suspected exposure to symptom onset is longer than a
month.
Risk factors for melioidosis include diabetes mellitus,
heavy alcohol consumption, chronic lung disease,
chronic renal disease, malignancy, and immunosup-
pressive treatment [3]. Patients with these risk factors
are predisposed to melioidosis, and previous studies
showed that 80e87% of melioidosis patients had at least
one risk factor [3,15,16]. Of the risk factors, diabetes
mellitus is most important. Diabetes has been reported
in 38e60% of melioidosis patients [17e20], and the
calculated risk of melioidosis in diabetics is as high as
21.2 (95% confidence interval 17.1e26.3) times the risk
in nondiabetics [16]. The presence of risk factors is
associated not only with susceptibility to the disease, but
also with its severity and clinical manifestations. The
chronic form of melioidosis was less common in dia-
betic patients and more commonly observed in patients
without risk factors. In addition, patients without risk
factors tended to have lower rates of bacteremia, septic
shock, and mortality [3]. In the present series, seven
(64%) patients had at least one risk factor, all of whom
were diabetic. Of the four patients without risk factors,
chronic infection was observed in three (75%) and two
(50%) had bacteremia. By contrast, none of the seven
patients with at least one risk factor developed a chronic
infection and all of them were bacteremic.
Previous reports showed that male sex is an inde-
pendent risk factor for melioidosis [16,21]. High occu-
pational exposure to soil and water is a significant risk
factor for melioidosis [22], and the association between
male sex and melioidosis is suggested to reflect an
increased exposure to B. pseudomallei [16]. In the pre-
sent series, all the cases were male, and this may also be
associated with high environmental exposure. Cases
with higher occupational exposure to soil and a pro-
longed duration of stay in an endemic area have a higher
chance of exposure to B. pseudomallei. Under the cur-
rent social circumstances of South Korea, men are more
likely to work in foreign countries for a long period, and
Imported melioidosis in South Korea 367this may explain the reason that all the patients are male.
In fact, only three cases in the present series were
tourists, and the remaining eight cases were those who
stayed in Southeast Asia for occupational purpose for
months to years.
The fatality rate of melioidosis ranges from 14% to
49% [3,17,18] and was reported to be as high as 65% in
bacteremic patients [19]. Old age (50 years), the pres-
ence of risk factors (diabetes, heavy alcohol use, and
chronic lung or renal disease), and markers of organ
dysfunction (leukopenia; raised liver enzyme, urea, and
creatinine levels; and acidosis) on admission are thought
to be associated with mortality [3,23,24]. In the present
series, four patients, three with diabetes and one elderly
patient, died from melioidosis. Two patients had septic
shock with evidence of organ dysfunction on admission.
The overall fatality rate was 36.4%. Despite its consid-
erable fatality rate, a recent study suggested that survival
is improving. In the Darwin study, the fatality rate from
melioidosis decreased from 30% to 9% over the past 20
years, and this was attributed to an early diagnosis, early
treatment with the appropriate antibiotics (ceftazidime or
meropenem), and access to intensive care management
[3]. Similarly, themortality ofmelioidosis in South Korea
may be reduced by an early diagnosis and initiation of the
proper antibiotics. Empirical antibiotic treatment often
does not cover B. pseudomallei, so an early suspicion of
melioidosis is essential.
Pneumonia is the most common presenting feature of
melioidosis, followed by genitourinary infection and
soft tissue infection [1,3]. Similarly, in this study, seven
(63.6%) patients presented with pneumonia, three
(27.3%) patients presented with genitourinary infection,
and one (9.1%) patient presented with soft tissue
infection. Abscesses were found in the prostate, spleen,
and liver, which are well-recognized sites of abscess
formation [3]. A mycotic aneurysm of the aorta was
observed in Case 5. Although very uncommon, mycotic
aneurysms due to melioidosis have been reported, and
are thought to be associated with high mortality and
relapse rates [25]. Therefore, melioidosis should be
suspected when patients with risk factors for melioidosis
present with a mycotic aneurysm. Moreover, although
pain is seen in the majority of patients, the presenting
symptoms of a mycotic aneurysm are often nonspecific
[25]. The patient in Case 5 denied any pain on admis-
sion, and the mycotic aneurysm was detected inciden-
tally in the process of evaluation of the fever focus.
Therefore, a mycotic aneurysm should be included in
the sites for further evaluation in melioidosis patients
whose primary infection focus is obscure.
Case 1 had a coinfection with pulmonary tuberculosis
and melioidosis. The patient was initially diagnosed
with pulmonary tuberculosis, but showed a poor
response to antitubercular treatment and was finally
diagnosed with melioidosis. Melioidosis might manifest
as a chronic pulmonary infection that mimics pulmonarytuberculosis and could be misdiagnosed as tuberculosis,
especially in areas endemic for tuberculosis, but not for
melioidosis [26]. Moreover, as in this case, a coinfection
of melioidosis and pulmonary tuberculosis can occur
[27], leading to considerable confusion in the treatment
process. Although not well established, previous case
reports suggested that mycobacterial infection is a risk
factor for melioidosis, reflecting host susceptibility to
intracellular pathogens [1]. The patient of Case 1 might
have had underlying pulmonary tuberculosis, and this
might have acted as a risk factor for melioidosis.
Increased suspicion for melioidosis is required when
patients with a history of visiting endemic regions pre-
sent with chronic pneumonia.
In summary, we presented the detailed epidemio-
logical and clinical features of the reported cases of
melioidosis from 2003 to 2014.Conflicts of interest
All authors have no conflicts of interest to declare.
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